| Basics |
argenx SE
argenx SE, along with its subsidiaries is engaged in the bio-technical research on drugs and pharma processes for the treatment of oncological, autoimmune and inflammatory diseases.
|
| IPO Date: |
May 18, 2017 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$51.39B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$4.03 | 1.51%
|
| Avg Daily Range (30 D): |
$7.70 | 0.97%
|
| Avg Daily Range (90 D): |
$6.91 | 1.02%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.2M |
| Avg Daily Volume (30 D): |
.29M |
| Avg Daily Volume (90 D): |
.34M |
| Trade Size |
| Avg Trade Size (Sh.): |
44 |
| Avg Trade Size (Sh.) (30 D): |
25 |
| Avg Trade Size (Sh.) (90 D): |
26 |
| Institutional Trades |
| Total Inst.Trades: |
1,772 |
| Avg Inst. Trade: |
$9.97M |
| Avg Inst. Trade (30 D): |
$28.17M |
| Avg Inst. Trade (90 D): |
$19.25M |
| Avg Inst. Trade Volume: |
.03M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$9.5M |
| Avg Closing Trade (30 D): |
$15.95M |
| Avg Closing Trade (90 D): |
$13.13M |
| Avg Closing Volume: |
21.12K |
|
|
|
|
|
